Company Filing History:
Years Active: 2012-2018
Title: Innovations by Andrew Finn in Transmucosal Drug Delivery
Introduction
Andrew Finn is an accomplished inventor based in Raleigh, NC, with a focus on developing innovative drug delivery systems. He holds a total of six patents, showcasing his commitment to advancing medical technology and improving patient care.
Latest Patents
Among his latest patents, Finn has developed a transmucosal drug delivery device specifically designed for chronic pain relief. This device allows for the administration of low doses of buprenorphine either twice daily or once daily, effectively treating chronic pain while minimizing significant side effects. Another notable invention is a method for enhancing transmucosal uptake of medications such as fentanyl or buprenorphine. This invention includes devices that facilitate the transmucosal administration of these medicaments, utilizing a mucoadhesive polymeric diffusion environment and a barrier environment to optimize delivery.
Career Highlights
Finn is currently associated with BioDelivery Sciences International, Inc., where he continues to innovate in the field of drug delivery systems. His work has significantly contributed to the development of effective pain management solutions.
Collaborations
Finn collaborates with Niraj Vasisht, leveraging their combined expertise to further enhance the efficacy of their inventions.
Conclusion
Andrew Finn's contributions to the field of drug delivery through his innovative patents demonstrate his dedication to improving healthcare solutions. His work continues to pave the way for advancements in chronic pain management.